Evaluation of α1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense

FASEB Journal

Volumn 14, Issue 11, 2000, Pages 1548-1558

  Obrosova, I G ^a   Van Huysen, C ^a   Fathallah, L ^a   Cao, X ^a   Stevens, M J ^a   Greene, D A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Motor nerve conduction; Nerve blood flow; Peripheral diabetic neuropathy; Prazosin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE; CREATINE PHOSPHATE; FRUCTOSE; GLUCOSE; INOSITOL; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PRAZOSIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; HYDROGEN CLEARANCE; MALE; METABOLISM; MOTOR NERVE CONDUCTION; NERVE FUNCTION; NEUROTROPISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033885820     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.99-0803com     Document Type: Article

References (101)

1. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy
2. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids (1995)
3. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: Comparison with an aldose reductase inhibitor
4. Neurovascular effects of L-carnitine treatment in diabetic rats
5. Effect of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats
6. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids
7. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy
8. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents
9. Nerve function and regeneration in diabetic and galactosemic rats: Antioxidant and metal chelator effects
10. Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor. WAY-121, 509, in streptozotocin-induced diabetic rats
11. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction, and tissue polyol pathway metabolites in streptozotocin-diabetic rats
12. +-ATPase activity and glutathione content in diabetic rats
13. Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: Interactions with the nitric oxide system
14. The potassium channel opener, WAY-1 35201, corrects nerve dysfunction in diabetic rats
15. Aminoguanidine effect on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals
16. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: Modulation by nitric oxide synthase inhibition
17. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats
18. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats
19. Effects of hindlimb temperature on sciatic nerve laser Doppler vascular conductance in control and streptozotocin-diabetic rats
20. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats
21. Increased sciatic nerve blood flow in diabetic rats: Assessment by 'molecular' vs. particulate microspheres
22. Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat
23. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat
24. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat
25. Experimental diabetic neuropathy: An update
26. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats
27. Effects of the peptide HP228 on nerve disorders in diabetic rats
28. The involvement of aldose reductase in diabetic complications
29. The role of aldose reductase in the development of diabetic complications
30. 1H-NMR analysis of nerve edema in the streptozotocin-induced diabetic rat
31. Complications: Neuropathy, pathogenetic considerations
32. Effects of hypoxia and severity of diabetes on Na,K-ATPase activity and arachidonyl-containing molecular species in streptozotocin-diabetic rat nerve
33. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide
34. Molecular species composition of glycerolipids in rat sciatic nerve and its alteration in streptozotocin-induced diabetes
35. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy
36. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy
37. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: A prevention study
38. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy
39. A Fluorometric method for determination of oxidized and reduced glutathione in tissues
40. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: Effect of DL-α-lipoic acid
41. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens
42. Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation
43. Amino acid analysis and enzymatic sequence determination of peptides by an improved O-phthaldialdehyde precolumn labeling procedure
44. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozotocin diabetes and its correction by dietary myoinositol supplementation
45. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat Liver
46. The redox state of free nicotinamide-adenine nucleotide phosphate in the cytoplasm of rat liver
47. The Gibbs-Donnan near-equilibrium system of heart
48. Impaired peripheral vasomotion in diabetes
49. Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes
50. Aminoguanidine - Effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats
51. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes
52. Blood flow in nerve and dorsal root ganglia in experimental diabetes; effects of insulin
53. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats
54. +-ATPase activity, and vascular supply in STZ-D rats
55. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve
56. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats
57. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits
58. Impaired energy utilization and Na-K-ATP-ase in diabetic peripheral nerve
59. Energy metabolism in rat brain in vivo studied by 31P nuclear magnetic resonance: Changes during postnatal development
60. Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy
61. Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves
62. Hyperglycemic pseudohypoxia and diabetic complications
63. Experimental chronic hypoxic neuropathy: Relevance to diabetic neuropathy
64. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus
65. Skin collagen glycation, glycoxidation, and cross-linking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: Relevance of glycated collagen products versus HbA1c as markers of diabetic complications
66. Glycation products and the pathogenesis of diabetic complications
67. Protein crosslinking by the Maillard reaction: Dicarbonyl-derived imidazolium crosslinks in aging and diabetes
68. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil
69. Quantitation of 3-deoxyglucosone levels in human plasma
70. Teratogenicity of 3-deoxyglucosone and diabetic embryopathy
71. 3-Deoxyglucosone: Metabolism, analysis, biological activity, and clinical implication
72. Metabolism of fructose-3-phosphate in the diabetic rat lens
73. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice
74. Effect of Schwann cell-specific over-expression of aldose reductase on diabetic and galactosemic neuropathy
75. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy
76. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy
77. Glucose-induced alterations in nerve metabolism: Current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy
78. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol
79. Effects of treatment with myoinositol or its 1,2,6-triphosphate (PP56) on nerve conduction in streptozotocin-diabetes
80. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism
81. Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients
82. Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance
83. Attenuation of nerve vascular and functional defects by nerve taurine replacement in the streptozotocin-diabetic rat
84. +-taurine co-transporter in streptozotocin-diabetic rats: A potential mediator of nerve ischemia
85. Taurine and eicosanoids in the heart
86. Taurine inhibits protein kinase C-catalyzed phosphorylation of specific proteins in a rat cortical P2 fraction
87. Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy
88. Nerve function and oxidative stress in diabetic and vitamin E-deficient rats
89. Nerve conduction and antioxidant levels in experimentally diabetic rats: Effects of streptozotocin dose and diabetes duration
90. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger. BM 15, 0639, in diabetic rats
91. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
92. Myelin splitting. Schwann cell injury and demyelination in feline diabetic neuropathy
93. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy
94. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia
95. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes
96. Regulation of JNK signaling by GSTp
97. Mitogen-activated protein kinases as glucose transducers for diabetic complications
98. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy
99. Oxidative stress, glutamate, and neurogenerative disorders
100. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices